Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus-Reference-Cited by-同舟云学术

Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus

Published:2020-12-27 Issue:3 Volume:32 Page:414-424
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatr Allergy Immunol

Author:

Luger Thomas¹^ORCID,Augustin Matthias²,Lambert Julien³,Paul Carle⁴,Pincelli Carlo⁵,Torrelo Antonio⁶,Vestergaard Christian⁷,Wahn Ulrich⁸,Werfel Thomas⁹

Affiliation:

1. Department of Dermatology University of Münster Münster Germany

2. University Medical Centre Hamburg‐Eppendorf Hamburg Germany

3. Department of Dermatology University Hospital of AntwerpUniversity of Antwerp Antwerp Belgium

4. Department of Dermatology Toulouse University Toulouse France

5. Laboratory of Cutaneous Biology Department of Surgical, Medical, Dental and Morphological Sciences University of Modena and Reggio Emilia Modena Italy

6. Department of Dermatology Hospital Infantil Universitario Niño Jesús Madrid Spain

7. Department of Dermatology Aarhus University Hospital Aarhus Denmark

8. Department for Pediatric Pneumology and Immunology Charité Medical University Berlin Germany

9. Department of Dermatology and Allergy Hannover Medical School Hannover Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pai.13422

Reference82 articles.

1. Atopic dermatitis